Noxopharm Ltd has released a press release.
Innovative collaboration further expands Sofra platform
Earlier from Noxopharm
- March 2026 Quarterly Activities Report and Appendix 4C
- Positive SOF-SKN dosing data shows prolonged skin retention
Noxopharm Ltd has released a press release.